Compare VCYT & BUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCYT | BUSE |
|---|---|---|
| Founded | 2006 | 1868 |
| Country | United States | United States |
| Employees | N/A | 1914 |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.5B |
| IPO Year | 2013 | 1996 |
| Metric | VCYT | BUSE |
|---|---|---|
| Price | $42.53 | $30.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $44.00 | $27.17 |
| AVG Volume (30 Days) | ★ 1.2M | 586.8K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 4.04% |
| EPS Growth | ★ 164.52 | N/A |
| EPS | 0.66 | ★ 1.20 |
| Revenue | N/A | ★ $719,584,000.00 |
| Revenue This Year | $13.76 | $23.84 |
| Revenue Next Year | $12.35 | $3.82 |
| P/E Ratio | $67.45 | ★ $25.56 |
| Revenue Growth | N/A | ★ 55.66 |
| 52 Week Low | $29.46 | $22.00 |
| 52 Week High | $60.91 | $31.70 |
| Indicator | VCYT | BUSE |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 55.27 |
| Support Level | $40.80 | $30.61 |
| Resistance Level | $46.15 | $31.70 |
| Average True Range (ATR) | 1.73 | 0.48 |
| MACD | 0.62 | -0.05 |
| Stochastic Oscillator | 75.06 | 55.79 |
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
First Busey Corporation is a financial holding company whose subsidiaries provide retail and commercial banking services, remittance processing, and offer financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech, and Wealth Management. The banking segment generates a vast majority of its revenue.